Gene expression analysis in these two highly homogeneous groups of patients indicates the potential role of IGF1 as one of the key signalling pathways involved in the development of intrinsic chemotherapy resistance in ovarian cancer. This evidence concerns the gene IGF1 and ovarian cancer.